Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 84Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Emay Pharmaceuticals

02 2Strides Pharma Science

03 3Acme Lifetech

04 12Aeon

05 2Aspire Lifesciences Pvt Ltd

06 1Avenza Pharmaceuticals

07 1Bio Labs

08 2Eris Lifesciences

09 2Euploid Pharmaceuticals

10 2Flagship Biotech International Pvt. Ltd

11 2Globela Pharma

12 2Halewood Laboratories Pvt. Ltd

13 2Indoco Remedies Limited

14 1Infugen Pharma

15 3Inventia Healthcare Limited

16 5Ipca Laboratories Limited

17 1Lucent Biotech Ltd

18 2Medreich

19 3Medvina Healthcare

20 2Neopharma

21 3Panacea Biotec Limited

22 2Pantson Pharma Pvt. Limited

23 3RELIANCE FORMULATION PVT. LTD

24 1RPG Life Sciences

25 1Ravenbhel Pharma

26 6Saudi Pharmaceutical Industries & Medical Appliances

27 2Scott-Edil Pharmacia

28 2Serene Pharma

29 2Stellapharm

30 1Symbiosis Pharma

31 2Synoptis Pharma

32 1Torrent Pharmaceuticals Limited

33 3Towa Pharma

34 2Vaishali Pharma Ltd

35 1Valpharma

36 1Vega Biotech Pvt. Ltd.

37 2World Medicine

38 1Xepa-Soul Pattinson m SDN BHD

39 1YICHANG HUMANWELL PHARMACEUTICAL CO., LTD

40 1YSK Laboratories

41 3Zim Laboratories

42 1Zota Healthcare Ltd

43 13Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEmay Pharmaceuticals is a GMP-certified API manufacturing company.

Regulatory Info :

Registration Country : India

Gliclazide

Brand Name : Gliclazide

Dosage Form : Sustained Release Gran...

Dosage Strength : 48%

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Emay Pharmaceuticals

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEmay Pharmaceuticals is a GMP-certified API manufacturing company.

Packaging :

Regulatory Info :

Gliclazide

Dosage : Sustained Release Gran...

Dosage Strength : 48%

Brand Name : Gliclazide

Approval Date :

Application Number :

Registration Country : India

Emay Pharmaceuticals

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Regulatory Info :

Registration Country : India

Gliclazide

Brand Name : Gliclazide

Dosage Form : Extended-Release Table...

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Packaging :

Regulatory Info :

Gliclazide

Dosage : Extended-Release Table...

Dosage Strength : 30MG

Brand Name : Gliclazide

Approval Date :

Application Number :

Registration Country : India

Strides Pharma Science

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Regulatory Info :

Registration Country : India

Gliclazide

Brand Name : Gliclazide

Dosage Form : Extended-Release Table...

Dosage Strength : 60MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Packaging :

Regulatory Info :

Gliclazide

Dosage : Extended-Release Table...

Dosage Strength : 60MG

Brand Name : Gliclazide

Approval Date :

Application Number :

Registration Country : India

Strides Pharma Science

04

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide

Brand Name :

Dosage Form : TABLET

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

04

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide

Dosage : TABLET

Dosage Strength : 40MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

05

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide

Brand Name : GLIVEON-80

Dosage Form : TABLET

Dosage Strength : 80MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

05

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide

Dosage : TABLET

Dosage Strength : 80MG

Brand Name : GLIVEON-80

Approval Date :

Application Number :

Registration Country : India

blank

06

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide; Sitagliptin Phosphate

Brand Name : AEOMET-GZ1

Dosage Form : SR TABLET

Dosage Strength : 30MG; 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

06

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide; Sitagliptin Phosphate

Dosage : SR TABLET

Dosage Strength : 30MG; 500MG

Brand Name : AEOMET-GZ1

Approval Date :

Application Number :

Registration Country : India

blank

07

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide; Sitagliptin Phosphate

Brand Name : AEOMET-GZ2

Dosage Form : SR TABLET

Dosage Strength : 60MG; 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

07

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide; Sitagliptin Phosphate

Dosage : SR TABLET

Dosage Strength : 60MG; 500MG

Brand Name : AEOMET-GZ2

Approval Date :

Application Number :

Registration Country : India

blank

08

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide; Sitagliptin Phosphate

Brand Name : AEOMET-G1

Dosage Form : BILAYERED TABLET

Dosage Strength : 1MG; 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

08

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide; Sitagliptin Phosphate

Dosage : BILAYERED TABLET

Dosage Strength : 1MG; 500MG

Brand Name : AEOMET-G1

Approval Date :

Application Number :

Registration Country : India

blank

09

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide; Sitagliptin Phosphate

Brand Name : AEOMET-G2

Dosage Form : BILAYERED TABLET

Dosage Strength : 2MG; 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

09

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide; Sitagliptin Phosphate

Dosage : BILAYERED TABLET

Dosage Strength : 2MG; 500MG

Brand Name : AEOMET-G2

Approval Date :

Application Number :

Registration Country : India

blank

10

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide; Pioglitazone Hydrochloride; Sitagliptin Phosphate

Brand Name : AEOMET-G1P

Dosage Form : BILAYERED TABLET

Dosage Strength : 1MG; 15MG; 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

10

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide; Pioglitazone Hydrochloride; Sitagliptin Phosphate

Dosage : BILAYERED TABLET

Dosage Strength : 1MG; 15MG; 500MG

Brand Name : AEOMET-G1P

Approval Date :

Application Number :

Registration Country : India

blank

11

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide; Pioglitazone Hydrochloride; Sitagliptin Phosphate

Brand Name : AEOMET-G2P

Dosage Form : BILAYERED TABLET

Dosage Strength : 2MG; 15MG; 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

11

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide; Pioglitazone Hydrochloride; Sitagliptin Phosphate

Dosage : BILAYERED TABLET

Dosage Strength : 2MG; 15MG; 500MG

Brand Name : AEOMET-G2P

Approval Date :

Application Number :

Registration Country : India

blank

12

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide; Pioglitazone Hydrochloride; Sitagliptin Phosphate

Brand Name : AEOMET-GC1P

Dosage Form : BILAYERED TABLET

Dosage Strength : 5MG; 15MG; 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

12

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide; Pioglitazone Hydrochloride; Sitagliptin Phosphate

Dosage : BILAYERED TABLET

Dosage Strength : 5MG; 15MG; 500MG

Brand Name : AEOMET-GC1P

Approval Date :

Application Number :

Registration Country : India

blank

13

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide; Pioglitazone Hydrochloride; Sitagliptin Phosphate

Brand Name : AEOMET-GZ1P

Dosage Form : BILAYERED TABLET

Dosage Strength : 15MG; 15MG; 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

13

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide; Pioglitazone Hydrochloride; Sitagliptin Phosphate

Dosage : BILAYERED TABLET

Dosage Strength : 15MG; 15MG; 500MG

Brand Name : AEOMET-GZ1P

Approval Date :

Application Number :

Registration Country : India

blank

14

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide

Brand Name :

Dosage Form : TABLET

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

14

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide

Dosage : TABLET

Dosage Strength : 30MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

15

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide

Brand Name :

Dosage Form : TABLET

Dosage Strength : 60MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

15

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide

Dosage : TABLET

Dosage Strength : 60MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

16

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide

Brand Name : Glycinorm

Dosage Form : TABLET

Dosage Strength : 80MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic CTD, ACTD, BE

Registration Country : India

blank

16

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide

Dosage : TABLET

Dosage Strength : 80MG

Brand Name : Glycinorm

Approval Date :

Application Number :

Registration Country : India

blank

17

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide

Brand Name :

Dosage Form : TABLETS

Dosage Strength : 40MG

Packaging : 3x10's, 10x10's

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

17

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide

Dosage : TABLETS

Dosage Strength : 40MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

18

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide

Brand Name :

Dosage Form : TABLETS

Dosage Strength : 80MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

18

OTS 2025
Not Confirmed
arrow

19

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide

Brand Name :

Dosage Form : TABLETS

Dosage Strength : 30MG

Packaging : 3x10's

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

19

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide

Dosage : TABLETS

Dosage Strength : 30MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

20

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Gliclazide

Brand Name :

Dosage Form : TABLETS

Dosage Strength : 60MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

20

OTS 2025
Not Confirmed
arrow